Effect of Processing and Sintering on Controlled Release Wax Matrix Tablets of Ketorolac Tromethamine
暂无分享,去创建一个
K. Thanki | M. Rao | S. Borate | G. Parikh | A. Ranpise
[1] Reena Singh,et al. Sintering of wax for controlling release from pellets , 2007, AAPS PharmSciTech.
[2] S. B. Tiwari,et al. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system , 2008, AAPS PharmSciTech.
[3] R. Löbenberg,et al. Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices. , 2005, Farmaco.
[4] B. S. Rao,et al. Design and evaluation of Eudragit RL 100 sintered matrix tablets , 2004 .
[5] D. Jung,et al. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration , 2004, European Journal of Clinical Pharmacology.
[6] B. S. Rao,et al. Design And Evaluation Of Ethylene Vinyl Acetate Sintered Matrix Tablets , 2003 .
[7] A. Nokhodchi,et al. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices. , 2002, International journal of pharmaceutics.
[8] A. Kondaiah,et al. Design Of Controlled Release Non-Erodible Polymeric Matrix Tablets Of Theophylline Using Sintering Technique , 2002 .
[9] B. S. Rao,et al. Studies On Release Of Rifampicin From Sintered Matrix Tablets , 2001 .
[10] F. Sarnquist,et al. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans. , 1987, Drug metabolism and disposition: the biological fate of chemicals.